Abstract: Uterine endometrial carcinoma is the most common malignant tumor of gynecological cancers. Standardization of treatment is urgently needed in the clinic, but there are many controversies regarding its treatment, such as the extent of surgery and the choice of adjuvant therapy modality. In recent years, there have been many clinical trials and investigations into these problems. Here we review the advances in treatment, in hopes of leading the way for the standardization of treatment for uterine endometrial carcinoma.